STAT+: Judges skewer HHS arguments in hearing over Medicare Advantage audits lawsuit
Federal judges pushed back against the government's arguments in a Medicare Advantage case.
Lees bij STAT News · 5 oktober 2026 om 20:13
STAT+: Judges skewer HHS arguments in hearing over Medicare Advantage audits lawsuit
Alle berichten over deze gebeurtenis, automatisch gegroepeerd uit meerdere onafhankelijke bronnen.
Laatst bijgewerkt: 5 oktober 2026 om 21:53 · 8 artikelen · 1 bronnen
STAT+: Nobel-winning optogenetics research has led to experimental treatments for blindness and Alzheimer’s
Optogenetics is now the foundational way through which we are able to understand how the brain works
Lees bij STAT News · 5 oktober 2026 om 20:08
STAT+: New Trump regulations would clean up health care pricing disclosures
The Trump administration is continuing its effort to bring more transparency to the cost of health care.
Lees bij STAT News · 5 oktober 2026 om 18:33
STAT+: Prices, prices, prices
Why is health insurance so expensive? Read the latest stort in STAT's "Out of Pocket, Out of Reach" series to find out.
Lees bij STAT News · 5 oktober 2026 om 16:38
STAT+: Utah plows ahead with more health AI pilots for prescriptions, women’s health
Utah plans to allow an AI product to evaluate patients and write new drug prescriptions without prior human review.
Lees bij STAT News · 5 oktober 2026 om 16:00
STAT+: Lilly’s Jaypirca approved as first-line CLL therapy
Eli Lilly’s Jaypirca has won FDA approval for previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma.
Lees bij STAT News · 5 oktober 2026 om 13:55
STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and more
Vaxcyte said its pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up a competition with Pfizer and Merck
Lees bij STAT News · 5 oktober 2026 om 13:10
STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market
Vaxcyte said its experimental pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up the biotech to compete with Pfizer and Merck.
Lees bij STAT News · 5 oktober 2026 om 12:19